Noticias de RCUS_US

Noticias del mercado

Últimas noticias sobre RCUS_US — 222 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: RCUS_US ✕ 222 resultados
20/04/2026 RCUS_US — Moomoo ES ← FR
Arcus Biosciences Inc - Fase 3 descontinuada

Arcus Biosciences Inc - Discontinues Phase 3

20/04/2026 RCUS_US — Investing.com
Arcus Biosciences stock falls on lung cancer trial halt
20/04/2026 RCUS_US — lwvtexas.org
Why Arcus Biosciences (RCUS) Stock Could Rise (Weakens) 2026-04-20 - Put Spread Alert
20/04/2026 RCUS_US — Bitget
According to the latest documents submitted to the U.S. Securities and Exchange Commission, the option rights held by Gilead Sciences in its previous cooperation agreement with Arcus Biosciences Inc. are set to officially expire on July 14, 2026.

According to the latest documents submitted to the U.S. Securities and Exchange Commission, the option rights held by Gilead Sciences in its previous cooperation agreement with Arcus Biosciences Inc. are…

20/04/2026 RCUS_US — Investing.com
Mizuho reiterates Arcus Biosciences stock rating after trial halt By Investing.com
20/04/2026 RCUS_US — Investing.com
Mizuho reiterates Arcus Biosciences stock rating after trial halt By Investing.com
20/04/2026 RCUS_US — Investing.com
Mizuho reiterates Arcus Biosciences stock rating after trial halt By Investing.com
20/04/2026 RCUS_US — Investing.com
Mizuho reiterates Arcus Biosciences stock rating after trial halt
20/04/2026 RCUS_US — Seeking Alpha
Arcus halts Gilead-partnered late-stage trial for lung cancer drug
20/04/2026 RCUS_US — TipRanks
Arcus Ends Key Lung Cancer Trials in Gilead Partnership Reset
20/04/2026 RCUS_US — AlphaStreet
Arcus Biosciences (RCUS) Drops 5.9% to $22.80
20/04/2026 RCUS_US — TradingView
Arcus Biosciences Inc - Discontinues Phase 3 Star-121 Study With Gilead Due To Futility
20/04/2026 RCUS_US — Stock Titan
[8-K] Arcus Biosciences, Inc. Reports Material Event
20/04/2026 RCUS_US — Investing.com
Arcus Biosciences stock falls on lung cancer trial halt By Investing.com
20/04/2026 RCUS_US — MarketScreener
Arcus Biosciences Inc - discontinues phase 3 star-121 study with Gilead due to futility
20/04/2026 RCUS_US — Investing.com
Arcus Biosciences ends STAR-121 lung cancer study and updates Gilead collaboration
20/04/2026 RCUS_US — Investing.com
Arcus Biosciences stock falls on lung cancer trial halt
20/04/2026 RCUS_US — MarketScreener
Arcus Biosciences Discontinues Phase 3 Lung Cancer Trial for Futility
20/04/2026 RCUS_US — Minichart
Arcus Biosciences, Inc. Files Form 8-K Reporting STAR-121 Update and Company Details (April 20, 2026)
20/04/2026 RCUS_US — GuruFocus
Arcus Biosciences (RCUS) Halts Late-Stage Lung Cancer Trial Amid Collaboration with Gilead

Página 10 de 12

keyboard_arrow_up